CN1259939C - 一种治疗口腔疾病的中药制剂及制备方法 - Google Patents
一种治疗口腔疾病的中药制剂及制备方法 Download PDFInfo
- Publication number
- CN1259939C CN1259939C CN 02150897 CN02150897A CN1259939C CN 1259939 C CN1259939 C CN 1259939C CN 02150897 CN02150897 CN 02150897 CN 02150897 A CN02150897 A CN 02150897A CN 1259939 C CN1259939 C CN 1259939C
- Authority
- CN
- China
- Prior art keywords
- preparation
- chinese medicine
- extractum
- decoct
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 54
- 239000003814 drug Substances 0.000 title claims abstract description 53
- 208000025157 Oral disease Diseases 0.000 title claims abstract description 10
- 208000030194 mouth disease Diseases 0.000 title claims abstract description 10
- 238000009472 formulation Methods 0.000 title claims description 6
- 239000000203 mixture Substances 0.000 title claims description 6
- 229940079593 drug Drugs 0.000 claims abstract description 21
- 208000002399 aphthous stomatitis Diseases 0.000 claims abstract description 18
- 208000007565 gingivitis Diseases 0.000 claims abstract description 13
- 230000002950 deficient Effects 0.000 claims abstract description 8
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 7
- 231100000614 poison Toxicity 0.000 claims abstract description 7
- 238000004128 high performance liquid chromatography Methods 0.000 claims abstract description 6
- 239000002574 poison Substances 0.000 claims abstract description 6
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 claims abstract description 5
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 claims abstract description 5
- 229940114124 ferulic acid Drugs 0.000 claims abstract description 5
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000001785 ferulic acid Nutrition 0.000 claims abstract description 5
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000000284 extract Substances 0.000 claims abstract description 4
- 239000007788 liquid Substances 0.000 claims description 37
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- 239000000796 flavoring agent Substances 0.000 claims description 13
- 235000019634 flavors Nutrition 0.000 claims description 13
- 239000012567 medical material Substances 0.000 claims description 13
- 230000000306 recurrent effect Effects 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 239000004480 active ingredient Substances 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 9
- 230000000202 analgesic effect Effects 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 239000007921 spray Substances 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 6
- 230000009467 reduction Effects 0.000 claims description 6
- 238000009834 vaporization Methods 0.000 claims description 6
- 230000008016 vaporization Effects 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 229940046011 buccal tablet Drugs 0.000 claims description 5
- 239000006189 buccal tablet Substances 0.000 claims description 5
- -1 collutory Substances 0.000 claims description 5
- 239000007938 effervescent tablet Substances 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000006196 drop Substances 0.000 claims description 4
- 229940040145 liniment Drugs 0.000 claims description 4
- 239000000865 liniment Substances 0.000 claims description 4
- 206010006326 Breath odour Diseases 0.000 claims description 3
- 208000032139 Halitosis Diseases 0.000 claims description 3
- 201000001245 periodontitis Diseases 0.000 claims description 3
- 238000007796 conventional method Methods 0.000 claims description 2
- 230000036407 pain Effects 0.000 abstract description 17
- 208000002193 Pain Diseases 0.000 abstract description 16
- 210000000214 mouth Anatomy 0.000 abstract description 15
- 230000000740 bleeding effect Effects 0.000 abstract description 6
- 231100000419 toxicity Toxicity 0.000 abstract description 4
- 230000001988 toxicity Effects 0.000 abstract description 4
- 238000005057 refrigeration Methods 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 238000005259 measurement Methods 0.000 abstract description 2
- 241000059156 Toddalia Species 0.000 abstract 2
- 206010067484 Adverse reaction Diseases 0.000 abstract 1
- 230000006838 adverse reaction Effects 0.000 abstract 1
- 230000017525 heat dissipation Effects 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 17
- 241001465754 Metazoa Species 0.000 description 14
- 239000008187 granular material Substances 0.000 description 10
- 230000037396 body weight Effects 0.000 description 9
- 208000032843 Hemorrhage Diseases 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 210000002200 mouth mucosa Anatomy 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 208000000114 Pain Threshold Diseases 0.000 description 5
- 102000011759 adducin Human genes 0.000 description 5
- 108010076723 adducin Proteins 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000037040 pain threshold Effects 0.000 description 5
- 206010053567 Coagulopathies Diseases 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000035602 clotting Effects 0.000 description 4
- 210000005069 ears Anatomy 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
- 240000006409 Acacia auriculiformis Species 0.000 description 3
- 241000581650 Ivesia Species 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 229930003448 Vitamin K Natural products 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 230000001680 brushing effect Effects 0.000 description 3
- 210000004195 gingiva Anatomy 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 3
- 229960004618 prednisone Drugs 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 235000019168 vitamin K Nutrition 0.000 description 3
- 239000011712 vitamin K Substances 0.000 description 3
- 150000003721 vitamin K derivatives Chemical class 0.000 description 3
- 229940046010 vitamin k Drugs 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- RATMHCJTVBHJSU-UHFFFAOYSA-N Dihydrochelerythrine Natural products C1=C2OCOC2=CC2=C(N(C)C(O)C=3C4=CC=C(C=3OC)OC)C4=CC=C21 RATMHCJTVBHJSU-UHFFFAOYSA-N 0.000 description 2
- 206010013183 Dislocation of vertebra Diseases 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 208000007117 Oral Ulcer Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- LLEJIEBFSOEYIV-UHFFFAOYSA-N chelerythrine Chemical compound C1=C2OCOC2=CC2=CC=C3C4=CC=C(OC)C(OC)=C4C=[N+](C)C3=C21 LLEJIEBFSOEYIV-UHFFFAOYSA-N 0.000 description 2
- 229940124579 cold medicine Drugs 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000001473 noxious effect Effects 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 210000005182 tip of the tongue Anatomy 0.000 description 2
- 231100000027 toxicology Toxicity 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010018286 Gingival pain Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- SLSIBLKBHNKZTB-UHFFFAOYSA-N Skimmianine Chemical compound COC1=C2C=COC2=NC2=C(OC)C(OC)=CC=C21 SLSIBLKBHNKZTB-UHFFFAOYSA-N 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 201000002661 Spondylitis Diseases 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000001772 anti-angiogenic effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000002951 depilatory effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- ALZAZMCIBRHMFF-UHFFFAOYSA-N dihydrochelerythrine Chemical compound C1=CC2=CC=3OCOC=3C=C2C2=C1C1=CC=C(OC)C(OC)=C1CN2C ALZAZMCIBRHMFF-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 231100000567 intoxicating Toxicity 0.000 description 1
- 230000002673 intoxicating effect Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940102535 prednisone 20 mg Drugs 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
组别 | 动物数(只) | 剂量(g/kg) | OD值 | P值 |
对照强的松高剂量中剂量低剂量 | 1010101010 | -0.027.55.02.5 | 0.23±0.030.12±0.040.13±0.030.16±0.040.21±0.03 | <0.01<0.01<0.01>0.05 |
组别 | 动物数(只) | 剂量(g/小时) | 肿胀度 | P值 | OD值 | P值 |
对照强的松高剂量 | 101010 | -0.027.5 | 18.90±2.6813.0±2.5514.20±1.32 | <0.01<0.01 | 0.12±0.020.08±0.010.09±0.02 | <0.01<0.01 |
中剂量低剂量 | 1010 | 5.02.5 | 16.50±1.3517.70±1.57 | <0.01>0.05 | 0.10±0.020.12±0.02 | <0.05>0.05 |
组别 | 动物数(只) | 剂量(g/kg) | 药前痛阈(秒) | 药后痛阈(秒) | ||
1小时 | 2小时 | 3小时 | ||||
对照强的松高剂量中剂量低剂量 | 1010101010 | -0.27.55.02.5 | 22.10±2.9222.10±3.2121.90±2.3322.30±3.0222.32±2.0 | 22.10±2.7237.73±6.29**39.0±4.58**36.0±2.49**26.80±3.22** | 22.80±2.2539.20±4.12**39.80±3.70**35.40±2.67**27.10±3.29** | 24.10±2.1838.10±3.60**38.20±3.52**33.6±2.11**26.90±4.55* |
组别 | 动物数(只) | 剂量(g/kg) | 10分钟扭体次数 | P值 |
对照阿斯匹林高剂量 | 101010 | -0.27.5 | 29.30±4.1115.60±8.8518.0±3.16 | <0.01<0.01 |
中剂量低剂量 | 1010 | 5.02.5 | 18.30±4.3924.50±3.31 | <0.01<0.05 |
组别 | 动物数(只) | 剂量(g/kg) | 停止出血时间(分) | P值 |
对照维生素K4高剂量中剂量低剂量 | 1010101010 | -0.0057.55.02.5 | 5.18±0.813.26±0.553.87±0.394.25±0.634.67±0.12 | <0.01<0.01<0.01<0.01 |
组别 | 动物数(只) | 剂量(g/kg) | 停止出血时间(分) | P值 |
对照 | 10 | - | 1.18±0.30 |
维生素K4高剂量中剂量低剂量 | 10101010 | 0.0057.55.02.5 | 0.61±0.190.69±0.180.75±0.241.08±0.21 | <0.01<0.01<0.01<0.05 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02150897 CN1259939C (zh) | 2002-11-29 | 2002-11-29 | 一种治疗口腔疾病的中药制剂及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02150897 CN1259939C (zh) | 2002-11-29 | 2002-11-29 | 一种治疗口腔疾病的中药制剂及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1504215A CN1504215A (zh) | 2004-06-16 |
CN1259939C true CN1259939C (zh) | 2006-06-21 |
Family
ID=34234148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02150897 Expired - Lifetime CN1259939C (zh) | 2002-11-29 | 2002-11-29 | 一种治疗口腔疾病的中药制剂及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1259939C (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2743427A1 (en) * | 2008-11-26 | 2010-06-03 | Perio Sciences, Llc | Antioxidant compositions for soft oral tissue and methods of formulation and use thereof |
CA2849910A1 (en) | 2011-09-30 | 2013-04-04 | Perio Sciences, Llc | Antioxidant compositions for treatment of inflammation or oxidative damage |
CN107397898A (zh) * | 2017-07-12 | 2017-11-28 | 田建波 | 一种治疗口腔病的中药组合物及其制备方法 |
CN111905025B (zh) * | 2020-09-14 | 2022-04-01 | 北京皓尔生物科技有限公司 | 一种治疗口腔溃疡、止血镇痛消炎的中药组合物及其制备方法与应用 |
-
2002
- 2002-11-29 CN CN 02150897 patent/CN1259939C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1504215A (zh) | 2004-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1210047C (zh) | 治疗感冒的药物及其制备方法 | |
CN105233061B (zh) | 复方中药漱口水 | |
CN1259939C (zh) | 一种治疗口腔疾病的中药制剂及制备方法 | |
CN114767824B (zh) | 一种治疗喉源性咳嗽的制剂及其制备方法 | |
CN1907374A (zh) | 一种防治口腔疾病的中药组合物 | |
CN100337645C (zh) | 一种治疗急性咽炎的药物组合物及其制备方法 | |
CN1596924A (zh) | 治疗口腔咽喉疾病的中西药复方 | |
CN104548020B (zh) | 一种药物组合物在制备治疗老年痴呆症药物中的用途 | |
CN1771981A (zh) | 一种痔疮膏 | |
CN1872326A (zh) | 一种治疗痔疮的外用药物组合物及其制备方法 | |
CN100335044C (zh) | 通窍鼻炎软胶囊及其制备工艺 | |
CN1939480A (zh) | 一种治疗损伤的中药复方制剂 | |
CN1237983C (zh) | 复方贯众阿司匹林制剂 | |
CN1799603A (zh) | 一种治疗风湿或类风湿的中药组合物及其制备方法 | |
CN1228068C (zh) | 一种具有祛风、除湿、止痛作用的药酒及制备方法和应用 | |
CN1282479C (zh) | 一种治疗口腔粘膜病的药物组合物及其制备方法 | |
CN1593564A (zh) | 一种治疗感冒的药物及其制备方法 | |
CN1101673C (zh) | 防治口腔病的口洁液及制备方法 | |
CN1895322A (zh) | 一种金感敏泡腾片及其制备方法 | |
CN1141113C (zh) | 一种治疗消化性溃疡的中成药 | |
CN100339116C (zh) | 咸味清咽润喉含片 | |
CN1176939C (zh) | 猪牙皂总皂苷及其制备方法与其在制备药物中的应用 | |
CN1714808A (zh) | 一种断血流分散片的制备方法 | |
CN1176688C (zh) | 一种治疗急慢性咽炎的药物及其制备方法 | |
CN1261121C (zh) | 一种治疗便秘、口臭、牙龈肿痛的药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Effective date of registration: 20090617 Pledge (preservation): Pledge |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20120412 Granted publication date: 20060621 Pledgee: Agricultural Bank of China Guiyang Wudang District subbranch Pledgor: GUIYANG XIN TIAN PHARMACEUTICAL Co.,Ltd. Registration number: 2009520000562 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Traditional Chinese medicine formulation for oral disease and its preparation method Effective date of registration: 20120412 Granted publication date: 20060621 Pledgee: Agricultural Bank of China Limited by Share Ltd. Guiyang Wudang branch Pledgor: GUIYANG XIN TIAN PHARMACEUTICAL Co.,Ltd. Registration number: 2012990000144 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20150423 Granted publication date: 20060621 Pledgee: Agricultural Bank of China Limited by Share Ltd. Guiyang Wudang branch Pledgor: GUIYANG XIN TIAN PHARMACEUTICAL Co.,Ltd. Registration number: 2012990000144 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Traditional Chinese medicine formulation for oral disease and its preparation method Effective date of registration: 20151202 Granted publication date: 20060621 Pledgee: Agricultural Bank of China Limited by Share Ltd. Guiyang Wudang branch Pledgor: GUIYANG XIN TIAN PHARMACEUTICAL Co.,Ltd. Registration number: 2015520000008 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20180606 Granted publication date: 20060621 Pledgee: Agricultural Bank of China Limited by Share Ltd. Guiyang Wudang branch Pledgor: GUIYANG XIN TIAN PHARMACEUTICAL Co.,Ltd. Registration number: 2015520000008 |
|
CX01 | Expiry of patent term |
Granted publication date: 20060621 |
|
CX01 | Expiry of patent term |